Testing LAE102 in healthy and overweight adults
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called LAE102 in two groups: healthy volunteers and people who are overweight or obese. The goal is to see if it is safe and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- For part A and B: BMI between 18.5 and 28 (healthy weight range). For part C: BMI between 26 and 40 (overweight or obesity range).
- Women must not be able to get pregnant, or have a negative pregnancy test.
- You must be generally healthy, with no major medical conditions.
- You cannot have used weight loss medications or GLP-1 drugs in the past 3 months (for part C).
- Your weight must have stayed stable (not changed more than 5%) in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injectable medication called SHR-1179 to see if it is safe and can help with weight loss. It is a placebo-controlled study, meaning some participants receive the drug and others receive an inactive shot, and no one knows which they get.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study is testing a new investigational drug, either alone or combined with another drug, to see how safe it is and how the body processes it. It is for healthy people who are overweight or obese, and results may help in developing future treatments for weight management.
This study tests an experimental medicine (LAE102) combined with a known weight-loss drug (tirzepatide) to see if it helps people with obesity lose more weight safely. You would receive the study drug or a placebo (a dummy shot), and the goal is to find a better way to manage weight.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
Hear when a new Overweight and Obese Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.